Pinetree – Talk Bio

Actionable Insights Powered by AI

Pinetree Therapeutics Secures $17M in Funding to Advance Targeted Protein Degraders

9 months ago talkbio0Tagged Drug Development, Funding, Pinetree, protein degraders, Series, TPD

Pinetree Therapeutics, targeted protein degraders, TPD, Series A funding, pharmaceutical development

AstraZeneca Acquires Pinetree’s EGFR Degrader for $45 Million Upfront

9 months ago talkbio0Tagged AstraZeneca, Cancer Therapeutic Procedure, Epidermal Growth Factor Receptor, licensing agreement, milestone payments, molecular glues, Neoplasms, Pinetree, Protein Degradation, Metabolic, protein degrader, royalties

AstraZeneca, Pinetree Therapeutics, EGFR degrader, protein degrader, oncology, licensing agreement, milestone payments, royalties, targeted protein degradation, molecular glues, cancer treatment